Bristol-Myers Squibb invests more than $UD 4 billion to discover and develop innovative medicines to help patients prevail against serious diseases.
In the past several years, we have delivered a number of new products for patients in need, including medicines for rheumatoid arthritis, hepatitis B, cancer and HIV/AIDS. As we look to the future, our pipeline continues to expand as we have approximately 55 compounds in development, of which, nearly half are biologics. Below is a list of the disease areas in which we focus:
- Fibrotic Diseases
- Exploratory Areas
In the true spirit of science, we are dedicated to educating and sharing our clinical trials information and data with patients, medical/research communities, the media, policy makers and the general public.
We act on our belief that the priceless ingredient of every product is the integrity of its maker.
Find information on all new or existing Bristol-Myers Squibb-sponsored